# AbbVie Inc. (ABBV) — Q3-2021 Earnings Results

**Report date:** 2021-10-29 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2021

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 4.56%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.33 | N/A | +3.26% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Confident

Overall, management conveyed confidence in the company's current trajectory. They noted strong performance in key areas, although no specific revenue guidance was provided.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing strength in their product portfolio.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

AbbVie's earnings report shows that the company performed well on EPS, exceeding expectations. The positive stock reaction of 4.56% suggests that investors are pleased with the results, particularly in light of the strong EPS performance. However, the lack of revenue figures and guidance may leave some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2021_